Huntington Ingalls Industries heads into its July 30 earnings report with short sellers cutting positions aggressively while options traders are becoming meaningfully more defensive — a split that defines the week's setup.
The most striking shift in positioning is the rapid retreat of short sellers. Short interest has fallen 25% over the past month, dropping to roughly 2% of the free float — a level that is genuinely low for any defense name carrying the kind of execution risk HII faces in naval shipbuilding. That retreat accelerated this week, with the short position declining another 13% in seven days to around 791,000 shares. Borrowing costs remain negligible at 0.48%, and availability is extremely loose — nearly 39 million shares sit available to borrow relative to the shares already shorted, a ratio that signals no squeeze pressure whatsoever. Short sellers are leaving, not building, and the borrow market offers nothing to stop them.
Options positioning tells a more cautious story. The put/call ratio has jumped to 0.64, well above its 20-day average of 0.45 — a move of more than one standard deviation — and that shift has been sustained across the past seven sessions rather than driven by a single print. The PCR ran near 0.35 through most of June before doubling in the final week of the month. That is not panic hedging, but it suggests investors buying protection ahead of the July 30 release at a rate meaningfully above recent norms. The 52-week PCR range spans 0.14 to 1.50, so the current level is nowhere near extreme, but the direction of travel is clear.
The Street remains broadly bullish despite consistently trimming targets. Citigroup, the most active name in analyst coverage, lowered its target to $349 as recently as July 1 — the second cut in six weeks — while maintaining its Buy rating. TD Cowen similarly cut to $420 in May and kept Buy. The pattern across the covering firms is one of preserved conviction with downward pressure on numbers, which fits a stock trading at $280 against a consensus target near $383. That implied upside of roughly 37% is striking but reflects the gap that has opened up after the stock dropped about 9% over the past month and is down roughly 18% year-to-date. The valuation has compressed with the price: the P/E has contracted more than two turns over 30 days to below 15x, and the EV/EBITDA multiple has eased to around 11.9x. Neither looks stretched for a prime defense contractor, which partly explains why the bulls are holding their ratings even as targets come down.
The earnings history adds relevant texture. The May 5 Q1 report delivered a 12% single-day drop, with the stock still down 8% five days later. The prior report in late April 2026 was closer to flat on the day. The historical pattern argues the market has already priced in meaningful downside risk — a read that would be consistent with both the low short interest and the elevated put/call ratio. Whether the July 30 print reopens the 12% drawdown scenario or vindicates the bulls who have been buying the dip at these multiples is the question the data sets up but cannot answer.
The stock closed at $279.89 on June 30, clawing back 0.9% on the day but still down 1.3% on the week. Most defense peers posted positive weeks — LMT gained 1.1%, RTX rose 1.8%, and KRMN surged 7.6% — which makes HII's continued underperformance relative to the sector a thread worth tracking as July 30 approaches.
See the live data behind this article on ORTEX.
Open HII on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
